HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


German Marketing Round-Up: Stada VMS Additions, Bayer On-The-Go Aspirin, Pädia Cough Switch

Executive Summary

The latest marketing news from Germany's OTC market: Stada extends Eunova VMS line with two launches; Bayer adds on-the-go pain relief option with Aspirin Complex; and Pädia launches levodropropizine-based cough suppressants under its Quimbo brand.

You may also be interested in...

Stada Enjoys Strong First Half With Sales Up By A Quarter

A combination of acquisitions, market share gains and successful product launches helped push Stada’s Consumer Healthcare sales up by a quarter in the first half as the German firm weathered tough macroeconomic conditions.

'Tectonic' Shifts In Germany’s OTC Market Require Smart Sales Strategies

Data from Sempora Consulting shows Germany's OTC market is still struggling to return to pre-pandemic growth levels in the first quarter of 2022. Digging deeper into recent trends like e-commerce and inflationary pricing, the firm suggests a number of points for consumer healthcare companies to consider in formulating their sales strategies for the rest of the year.

Is It Time For German OTC Firms To Tune Into The Global TV Shopping Renaissance?

Consumers across the world are switching to TV shopping channels like QVC to buy their cosmetic products and food supplements. Sempora Consulting looks at how this trend is playing out in Germany, and the opportunity for OTC firms looking to branch out into this newly fashionable retail channel.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts